ISSN: 1758-4299

Journal Home

Clinical Lipidology Unclaimed

Taylor & Francis Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Lipidology is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine with an H index of . It is an CC BY-NC Journal with a Double blind peer review review system, and It has a price of 847 €. The scope of the journal is focused on lipidology, cardiovascular diseases, lipid-related disorders, lipids, obesity. It is published in English.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (-) Endocrinology, Diabetes and Metabolism (-)

Price

847 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

-

SJR Impact factor

-

H Index

-

Total Docs (Last Year)

-

Total Docs (3 years)

-

Total Refs

-

Total Cites (3 years)

-

Citable Docs (3 years)

-

Cites/Doc (2 years)

-

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Endocrine Reviews Q1
Nature Reviews Endocrinology Q1
Nature Metabolism Q1
Diabetes Care Q1
Bone Research Q1

Compare this journals

Aims and Scope

Lipidology Cardiovascular diseases Lipid-related disorders Lipids Obesity

Best articles by citations

Intestinal electrical stimulation and the promotion of fat excretion: a potential treatment for obesity?

Conjugated linoleic acids and inflammation: isomer- and tissue-specific responses

Starting early to control all risk factors in order to prevent coronary heart disease

The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus

Thyroid function and PCSK9 in euthyroid subjects with coronary artery disease

Paraoxonase 1 interactions with atherosclerotic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development

Managing recalcitrant hypercholesterolemia in patients on current best standard of care: efficacy and safety of novel pharmacotherapies

Proresolving mediators: new therapies to treat inflammatory diseases

Periodontitis, blood lipids and lipoproteins

Phospholipase A2 as a therapeutic target for atherosclerosis

Variations in lipid levels according to menstrual cycle phase: clinical implications

SORT1: deciphering the biological and genetic link between cholesterol and coronary heart disease

SHOW MORE ARTICLES

Gene-environment interactions and the impact on obesity and lipid profile phenotypes

Atorvastatin: a review of its pharmacological properties and use in familial hypercholesterolemia

Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?

Hyperlipidemia in racial/ethnic minorities: differences in lipid profiles and the impact of statin therapy

Metabolic shifts during cardiac hypertrophy

Screening for familial hypercholesterolemia: primary care applications

PCSK9 and heart disease: quieting an outdated metabolic moderator

Will new statin guidelines lead to overtreatment?

Factors affecting proteoglycan synthesis and structure that modify the interaction with lipoproteins

50th International Conference on the Bioscience of Lipids

Assessment of thyroid hormones status and some adipocytokines among Egyptian obese children

Mammalian diseases of phosphatidylinositol transfer proteins and their homologs